What to do with antinuclear antibodies 1:3200

Antinuclear antibody 1:3200 suggests that autoimmune diseases, chronic infections or tumors may exist. Patients should consult a doctor for a clear diagnosis in time, and according to the cause of the disease, they should be treated with immunosuppressants, anti-infections or radiotherapy.
Low titers of antinuclear antibodies can be seen in autoimmune diseases, chronic infections or tumors. False-positive antinuclear antibodies can be seen in some normal people, but the titer is usually low; elevated antinuclear antibody 1:3200 is more likely to be associated with autoimmune diseases such as systemic lupus erythematosus (SLE), chronic infections, and neoplasms.
In autoimmune diseases such as systemic lupus erythematosus, dry syndrome, systemic sclerosis, etc., it is often combined with a significant increase in the titer of antinuclear antibody, accompanied by other clinical manifestations of the disease, such as pteronuclear erythema on the face, dryness of the eyes and mouth, thickening of the skin, and fever. Patients should be regulated with glucocorticosteroids such as prednisone, and immunosuppressive agents such as cyclophosphamide.
Chronic infectious diseases, such as chronic bronchial dilatation, tuberculosis, etc., may also have elevated titers of antinuclear antibodies, and patients should undergo anti-infectious treatment under the guidance of a doctor; such as lymphoma, leukemia and other oncological diseases may also have elevated titers of antinuclear antibodies, and such patients should undergo the appropriate radiotherapy as prescribed by a doctor.
Patients with anti-nuclear antibody 1:3200 should go to regular hospitals as soon as possible for diagnosis and standardized treatment. Drugs should be used in accordance with the doctor’s instructions, do not self-medication, so as not to delay the condition.